Assessment of Optimal Size and Composition of the U.S. National Registry of Hematopoietic Stem Cell Donors
- 15 July 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 78 (1) , 89-95
- https://doi.org/10.1097/01.tp.0000132327.40702.97
Abstract
The National Marrow Donor Program (NMDP) receives federal funding to operate a registry of over 4 million volunteer donors for patients in need of a hematopoietic stem cell transplant. Because minority patients are less likely to find a suitably matched donor than whites, special efforts have been aimed toward recruitment of minorities. Significant financial resources are required to recruit and tissue type additional volunteer donors. Population genetics models have been constructed to project likelihoods of finding a human leukocyte antigen (HLA)-matched donor for patients of various racial/ethnic groups. These projections have been made under a variety of strategies for expansion of the NMDP Registry. Cost-effectiveness calculations incorporated donor unavailability and other barriers to transplantation. At current recruitment rates, the probability of an available HLA-A,B,DRB1 matched donor is projected to increase from 27% to 34%; 45% to 54%; 75% to 79%; and 48% to 55%, for blacks, Asians/Pacific Islanders, whites and Hispanics, respectively, by the year 2007. Substantial increases in minority recruitment would have only modest impacts on these projections. These projections are heavily affected by donor availability rates, which are less than 50% for minority volunteers. Continued recruitment of additional volunteers can improve the likelihood of finding an HLA-matched donor, but will still leave significant numbers of patients of all racial/ethnic groups without a match. Efforts to improve donor availability (especially among minorities) and to increase the number of patients with access to the NMDP Registry may prove to be more cost-effective means of increasing transplants.Keywords
This publication has 23 references indexed in Scilit:
- The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donorsBlood, 2002
- The National Marrow Donor ProgramCancer, 2001
- Optimizing Outcome After Unrelated Marrow Transplantation by Comprehensive Matching of HLA Class I and II Alleles in the Donor and RecipientBlood, 1998
- HLA GENE AND HAPLOTYPE FREQUENCIES IN THE NORTH AMERICAN POPULATIONTransplantation, 1997
- Understanding donors' motivations: A study of unrelated bone marrow donorsSocial Science & Medicine, 1997
- IMPACT OF RACIAL GENETIC POLYMORPHISM ON THE PROBABILITY OF FINDING AN HLA-MATCHED DONORTransplantation, 1995
- Large‐scale oligonucleotide typing for HLA‐DRB1/3/4 and HLA‐DQB1 is highly accurate, specific, and reliableTissue Antigens, 1993
- Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor ProgramNew England Journal of Medicine, 1993
- MARROW TRANSPLANTATION FROM HLA-MATCHED UNRELATED DONORS FOR TREATMENT OF HEMATOLOGIC MALIGNANCIESTransplantation, 1991
- On willingness to be a bone marrow donorTransfusion, 1986